Radiomics In Pancreatic Cancer

$0.00

Clinical Trial Record

Return to Clinical Trials

Study Start

2016-01

Primary Completion (ESTIMATED)

2023-12

Study Completion (ESTIMATED)

2024-12

Enrollment (ESTIMATED)

2000

Study Overview

Radiomics in Pancreatic Cancer

The images of patients with pancreatic cancer were collected and analyzed based on the methodes of radiomics

N/A

Pancreatic Cancer

Retro-001

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates	Results Reporting Dates	Study Record Updates
First Submitted 2022-12-05	Results First Submitted N/A	Last Update Submitted that met QC Criteria 2022-12-13
First Submitted that Met QC Criteria 2022-12-13	Results First Submitted that Met QC Criteria N/A	Last Update Posted (ACTUAL) 2022-12-21
First Posted (ACTUAL) 2022-12-21	Results First Posted N/A	Last Verified 2022-12

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
N/A

Allocation:
N/A

Interventional Model:
N/A

Masking:
N/A

Arms and Interventions

Participant Group/Arm	Intervention/Treatment
: patients with pancreatic cancer Patients with pancreatic tumors diagnosed clinically or pathologically
: Participants without pancreatic cancer Participants who judged the pancreas to be completely healthy through medical examination

Primary Outcome Measures	Measure Description	Time Frame
5-year survival rate		1 week

Secondary Outcome Measures	Measure Description	Time Frame

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:
1

Gender unlimited, 18-80 years old;
Received abdominal imaging;
informed consent signed.

Pregnant / lactating women；
Contraindications of imaging examination。

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Fu N, Fu W, Chen H, Chai W, Qian X, Wang W, Jiang Y, Shen B. A deep-learning radiomics-based lymph node metastasis predictive model for pancreatic cancer: a diagnostic study. Int J Surg. 2023 Aug 1;109(8):2196-2203. doi: 10.1097/JS9.0000000000000469.

Learn

Resources

PatientS

Caregivers

Clinical Trial Record